02696.HK 財務： Shanghai Henlius Biotech, Inc. AI 分析

Q: 技術分析指標如何適用於 02696.HK？

根據技術分析，Shanghai Henlius Biotech, Inc. 的綜合信號為 Buy。Shanghai Henlius Biotech, Inc. 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

Q: 02696.HK 的費波那契回檔水準是多少？

Shanghai Henlius Biotech, Inc. 的費波那契回檔水準是 介於 61.8% 和 78.6% 之間。

Q: Shanghai Henlius Biotech, Inc. 的 RSI 是多少？

Shanghai Henlius Biotech, Inc. 的 RSI 目前為 66.11，表明處於 中立 狀態

Q: Shanghai Henlius Biotech, Inc. 接下來 12 個月的價格是多少？

Shanghai Henlius Biotech, Inc. 02696.HK 接下來 12 個月的價格預估為 $0。

Q: Shanghai Henlius Biotech, Inc. 預計會漲到多高？

據華爾街分析師稱，Shanghai Henlius Biotech, Inc. 預計將達到 $0 的高預測值。

首頁

股票

02696.HK

預測

HENLIUS (02696.HK)

Shanghai Henlius Biotech, Inc.

HK$68.25

1.26%

$0.84

休市： Jan 16, 16:00:00 HKT

關鍵數據

前收市價

$67.4

開盤價

$67.4

當日範圍

$66.55 - $69.9

52週區間

$15.2 - $92

交易量

384.1K

平均成交量

1.1M

每股盈餘 (TTM)

1.69

股息收益率

市值

$11.1B

什麼是 HENLIUS？

Shanghai Henlius Biotech, Inc. engages in the production and sale of monoclonal antibody (mAb) drugs and the provision of related consultation and technical services, and the transfer of its own technology. The company is headquartered in Shanghai, Shanghai and currently employs 3,537 full-time employees. The company went IPO on 2019-09-25. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The firm mainly operates its businesses in the domestic and overseas markets.

功能特性

交易策略

資源

市場

02696.HK 股價預測摘要

02696.HK stock price ended at $68.25 on 星期五, after rising 1.26%

On the latest trading day Jan 16, 2026, the stock price of 02696.HK rose by 1.26%, climbing from $67.40 to $68.25. During the session, the stock saw a volatility of 5.03%, with prices oscillating between a daily low of $66.55 and a high of $69.90. Notably, trading volume dropped by 123.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 381.1K shares were traded, equating to a market value of approximately $11.1B.

02696.HK 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

02696.HK 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 1.56%。整體而言，技術指標顯示中期後市趨勢為 Buy。

02696.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為02696.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 02696.HK？



02696.HK 的費波那契回檔水準是多少？



Shanghai Henlius Biotech, Inc. 的 RSI 是多少？



Shanghai Henlius Biotech, Inc. 接下來 12 個月的價格是多少？



Shanghai Henlius Biotech, Inc. 預計會漲到多高？



Shanghai Henlius Biotech, Inc.（02696.HK）價格

02696.HK 股價走勢圖